Brain Tumor Drug Developer Celldex Prices $174M Offering
Celldex Therapeutics Inc. is looking to raise $174 million in an underwritten stock offering that the biotechnology company priced at $24 per share Thursday as the company looks to capitalize on...To view the full article, register now.
Already a subscriber? Click here to view full article